epinastine
epinastine
SMILES | N=C1NCC2c3ccccc3Cc3ccccc3N12 |
InChIKey | WHWZLSFABNNENI-UHFFFAOYSA-N |
Chemical Properties
Hydrogen bond acceptors | 1 |
Hydrogen bond donors | 2 |
Rotatable bonds | 0 |
Molecular weight (Da) | 249.1 |
Database connections
Ligand site mutations | H1 |
Bioactivities
Receptor | Activity | Source | |||||||
---|---|---|---|---|---|---|---|---|---|
Protein | Gene | Species | Family | Class | Type | Min | Avg | Max | Database |
Receptor | Activity | Source | |||||||
---|---|---|---|---|---|---|---|---|---|
Protein | Gene | Species | Family | Class | Type | Min | Avg | Max | Database |
epinastine
Drug properties
Molecular type | Small molecule |
Physiological/Surrogate | Surrogate |
Approved drug | Yes |
Distribution across phases (no. indications)
Phase I
0
Phase II
0
Phase III
6
Phase IV
4
Database connections
Ligand site mutations | H1 |
Sankey plot
Drug Information
Target | Disease | ||||||||
---|---|---|---|---|---|---|---|---|---|
Gene | Protein | Receptor family | Ligand type | Class | Name | Phase | ICD11 | ATC | Association score |